Top Small Cap Stocks For 2019

&l;p&g;Jeff Meyers founded Cobia Capital, a value oriented long/short equity fund in 2008. &a;nbsp;In the decade since, Meyers&a;nbsp;has carved out a niche and reputation for himself unmatched within the small cap technology space. &a;nbsp;He has consistently been one of the top ranked analysts on SumZero, where he has generated&a;nbsp;a staggering median annualized return of&a;nbsp;26.31% across 34 ideas. &a;nbsp; Meyers has&a;nbsp;topped SumZero&s;s Best All-Time, Long, and Value Rankings lists. Prior to launching Cobia,&a;nbsp;Meyers had a long career on the buyside, with roles as Managing Director at Intrepid Capital, Portfolio Manager at Ibis, and Portfolio Manager at Ivory Capital.

I&a;nbsp;sat down with Meyers&a;nbsp;to hear about his European small cap strategy and his thoughts on value investing.

&l;img class=&q;dam-image bloomberg size-large wp-image-42441613&q; src=&q;https://specials-images.forbesimg.com/dam/imageserve/42441613/960×0.jpg?fit=scale&q; data-height=&q;640&q; data-width=&q;960&q;&g; Michael Nagle/Bloomberg

Top Small Cap Stocks For 2019: China Metro-Rural Holdings Limited(CNR)

Advisors’ Opinion:

  • [By Max Byerly]

    Press coverage about Canadian National Railway (NYSE:CNI) (TSE:CNR) has been trending somewhat positive on Thursday, according to Accern Sentiment Analysis. Accern identifies positive and negative press coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Canadian National Railway earned a coverage optimism score of 0.15 on Accern’s scale. Accern also gave media coverage about the transportation company an impact score of 47.5112066080017 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

  • [By Joseph Griffin]

    Shares of Canadian National Railway (TSE:CNR) (NYSE:CNI) have been given an average recommendation of “Buy” by the eleven research firms that are covering the firm, MarketBeat reports. One investment analyst has rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average 12-month price target among brokerages that have updated their coverage on the stock in the last year is C$109.36.

  • [By Max Byerly]

    Compass Capital Management Inc. bought a new position in Canadian National Railway (NYSE:CNI) (TSE:CNR) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 2,535 shares of the transportation company’s stock, valued at approximately $207,000.

  • [By Stephan Byrd]

    Brokerages expect Canadian National Railway (NYSE:CNI) (TSE:CNR) to announce earnings of $1.03 per share for the current fiscal quarter, Zacks Investment Research reports. Eight analysts have issued estimates for Canadian National Railway’s earnings, with the highest EPS estimate coming in at $1.10 and the lowest estimate coming in at $0.97. Canadian National Railway reported earnings of $1.00 per share in the same quarter last year, which would indicate a positive year over year growth rate of 3%. The business is scheduled to issue its next quarterly earnings report on Tuesday, July 24th.

  • [By Max Byerly]

    Canadian National Railway (NYSE:CNI) (TSE:CNR) – Cormark raised their Q3 2018 earnings per share (EPS) estimates for Canadian National Railway in a research report issued to clients and investors on Tuesday, April 10th. Cormark analyst D. Tyerman now expects that the transportation company will post earnings per share of $1.15 for the quarter, up from their previous estimate of $1.14.

  • [By Shane Hupp]

    Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp cut its position in Canadian National Railway (NYSE:CNI) (TSE:CNR) by 21.1% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,956,400 shares of the transportation company’s stock after selling 522,300 shares during the period. Canadian National Railway accounts for about 1.7% of Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp’s investment portfolio, making the stock its 7th biggest position. Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp owned 0.27% of Canadian National Railway worth $184,215,000 at the end of the most recent reporting period.

Top Small Cap Stocks For 2019: FuelCell Energy Inc.(FCEL)

Advisors’ Opinion:

  • [By Paul Ausick]

    FuelCell Energy Inc. (NASDAQ: FCEL) posted a decrease of 25.7% in short interest during the period. Some 5.86 million shares were short as of April 30. The stock closed at $1.93 on Wednesday, up about 1.6% for the day, in a 52-week range of $0.80 to $2.49. Shares traded down about 7.8% in the short interest period, and days to cover rose from six to eight.

  • [By Shane Hupp]

    FuelCell Energy Inc (NASDAQ:FCEL) shares traded up 5.8% on Friday . The stock traded as high as $1.49 and last traded at $1.45. 12,581,855 shares traded hands during trading, an increase of 983% from the average session volume of 1,161,380 shares. The stock had previously closed at $1.37.

  • [By Paul Ausick]

    FuelCell Energy Inc. (NASDAQ: FCEL) posted an increase of 43.9% in short interest during the period. Some 10.68 million shares were short as of June 29. The stock closed most recently at $1.33, down about 1.5% for the day, in a 52-week range of $1.29 to $2.49. Shares traded down more than 20% in the short interest period, and days to cover dropped from six to four.

  • [By Peter Graham]

    Small cap fuel cell stockFuelCell Energy Inc (NASDAQ: FCEL) reported Q4 and fiscal year ended October 31, 2017 earningswithQ4 total revenuesbeing $47.9 million versus $24.5 million:

  • [By Shane Hupp]

    Electro Scientific Industries (NASDAQ: ESIO) and FuelCell Energy (NASDAQ:FCEL) are both small-cap computer and technology companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, risk, profitability, dividends and earnings.

  • [By Paul Ausick]

    FuelCell Energy Inc. (NASDAQ: FCEL) posted a decrease of 4% in short interest during the period. Some 7.42 million shares were short as of June 15. The stock closed at $1.37 on Tuesday, down about 1.4% for the day, in a 52-week range of $1.18 to $2.49. Shares traded down more than 10% in the short interest period, and days to cover dropped from 17 to six.

Top Small Cap Stocks For 2019: Petroquest Energy Inc(PQ)

Advisors’ Opinion:

  • [By Ethan Ryder]

    News headlines about Petroquest Energy (NYSE:PQ) have been trending somewhat positive recently, Accern Sentiment Analysis reports. Accern identifies negative and positive news coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Petroquest Energy earned a coverage optimism score of 0.05 on Accern’s scale. Accern also gave news stories about the energy company an impact score of 47.638327846877 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

Top Small Cap Stocks For 2019: Achillion Pharmaceuticals Inc.(ACHN)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Achillion Pharmaceuticals (NASDAQ:ACHN) – Research analysts at B. Riley reduced their FY2018 EPS estimates for shares of Achillion Pharmaceuticals in a research note issued to investors on Wednesday, May 2nd. B. Riley analyst M. Kumar now anticipates that the biopharmaceutical company will earn ($0.58) per share for the year, down from their previous estimate of ($0.55). B. Riley has a “Neutral” rating and a $3.50 price objective on the stock. B. Riley also issued estimates for Achillion Pharmaceuticals’ FY2019 earnings at ($0.64) EPS, FY2020 earnings at ($0.71) EPS, FY2021 earnings at ($0.70) EPS and FY2022 earnings at ($0.84) EPS.

  • [By Stephan Byrd]

    Achillion Pharmaceuticals (NASDAQ:ACHN) has been given an average recommendation of “Hold” by the nine brokerages that are currently covering the firm, MarketBeat reports. Two analysts have rated the stock with a sell rating, four have issued a hold rating and three have issued a buy rating on the company. The average 12 month price target among analysts that have covered the stock in the last year is $5.20.

  • [By Keith Speights]

    Skeptics might deride a comparison of Inovio Pharmaceuticals, Inc. (NASDAQ:INO) and Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) as an exercise in finding the biggest loser. Both companies continue to post huge net losses every quarter, and their stocks are down by at least 30% over the last 12 months.

Leave a Reply

Your email address will not be published. Required fields are marked *